|
1
|
Longo DL, Reck M and Rabe KF: Precision
diagnosis and treatment for advanced non-small-cell lung cancer. N
Engl J Me. 377:849–861. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:4462018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rittmeyer A, Barlesi F, Waterkamp D, Park
K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols
MC, et al: Atezolizumab versus docetaxel in patients with
previously treated non-small-cell lung cancer (OAK): A phase 3,
open-label, multicentre randomised controlled trial. Lancet.
389:255–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pless M, Stupp R, Ris HB, Stahel RA, Weder
W, Thierstein S, Gerard MA, Xyrafas A, Früh M, Cathomas R, et al:
Induction chemoradiation in stage IIIA/N2 non-small-cell lung
cancer: A phase 3 randomised trial. Lancet. 1049–1056. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song Y, Zhou B, Du X, Wang Y, Zhang J, Ai
Y, Xia Z and Zhao G: Folic acid (FA)-conjugated mesoporous silica
nanoparticles combined with MRP-1 siRNA improves the suppressive
effects of myricetin on non-small cell lung cancer (NSCLC). Biomed
Pharmacother. 125:1095612020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gandara DR, Hammerman PS, Sos ML, Lara PN
Jr and Hirsch FR: Squamous cell lung cancer: From tumor genomics to
cancer therapeutics. Clin Cancer Res. 21:2236–2243. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mentzelopoulos A, Gkiatis K, Karanasiou I,
Karavasilis E, Papathanasiou M, Efstathopoulos E, Kelekis N,
Kouloulias V and Matsopoulos GK: Chemotherapy-induced brain effects
in small-cell lung cancer patients: A multimodal MRI study. Brain
Topogr. 34:167–181. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lo YL, Hsiao CF, Chang GC, Tsai YH, Huang
MS, Su WC, Chen YM, Hsin CW, Chang CH, Yang PC, et al: Risk factors
for primary lung cancer among never smokers by gender in a matched
case-control study. Cancer Causes Control. 24:567–576. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kabir Z, Bennett K and Clancy L: Lung
cancer and urban air-pollution in Dublin: A temporal association?
Ir Med J. 100:367–369. 2007.PubMed/NCBI
|
|
11
|
Loomis D, Grosse Y, Lauby-Secretan B, El
Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock
H, Straif K, et al: The carcinogenicity of outdoor air pollution.
Lancet Oncology. 14:1262–1263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yue N, Ye M, Zhang R and Guo Y:
miR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell
proliferation in lung adenocarcinoma. BMC Pulm Med. 20:1522020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao Y, Meng H, Liu S, Hu J, Zhang Y, Jiao
T, Liu Y, Ou J, Wang D, Yao L, et al: lncRNA-HOST2 regulates cell
biological behaviors in epithelial ovarian cancer through a
mechanism involving microRNA let-7b. Hum Mol Genet. 24:841–852.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Katsushima K, Natsume A, Ohka F, Shinjo K,
Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, et
al: Targeting the Notch-regulated non-coding RNA TUG1 for glioma
treatment. Nat Commun. 7:136162016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schaukowitch K and Kim TK: Emerging
epigenetic mechanisms of long non-coding RNAs. Neuroscience.
264:25–38. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Monroig Pdel C, Chen L, Zhang S and Calin
GA: Small molecule compounds targeting miRNAs for cancer therapy.
Adv Drug Deliv Rev. 81:104–116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng G, Liu D, Liang H, Yang H, Chen K
and Zhang X: A cluster of long non-coding RNAs exhibit diagnostic
and prognostic values in renal cell carcinoma. Aging (Albany NY).
11:9597–9615. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Simpson RJ, Lim JW, Moritz RL and
Mathivanan S: Exosomes: Proteomic insights and diagnostic
potential. Expert Rev Proteomics. 6:267–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui Y, Fan Y, Zhao G, Zhang Q, Bao Y, Cui
Y, Ye Z, Chen G, Piao X, Guo F, et al: Novel lncRNA PSMG3AS1
functions as a miR1433p sponge to increase the proliferation and
migration of breast cancer cells. Oncol Rep. 43:229–239.
2020.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang W and Wang M: New insights into the
immunomodulatory role of exosomes in cardiovascular disease. Rev
Cardiovasc Med. 20:153–160. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Huo Z, Wang W, Zhai S, Wang Y, Weng
Y, Deng X and Lu X: Construction and integrated analysis of a
lncRNA-associated competing endogenous RNA network reveal
functional lncRNAs in pancreatic cancer. Transl Cancer Res.
9:3643–3657. 2020. View Article : Google Scholar
|
|
24
|
Liu QY, Miao Y, Wang XH, Wang P, Cheng ZC
and Qian TM: Increased levels of miR-3099 induced by peripheral
nerve injury promote Schwann cell proliferation and migration.
Neural Regen Res. 14:525–531. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen L, Wang G, Xu Z, Lin K, Mu S, Pan Y
and Shan M: Overexpression of lncRNA PSMG3-AS1 distinguishes
glioblastomas from sarcoidosis. J Mol Neurosci. 70:2015–2019. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Okkenhaug K and Vanhaesebroeck B: PI3K in
lymphocyte development, differentiation and activation. Nat Rev
Immunol. 3:317–330. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meo AD, Bartlett J, Cheng Y, Pasic MD and
Yousef GM: Liquid biopsy: A step forward towards precision medicine
in urologic malignancies. Mol Cancer. 16:802017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kalwa M, Hänzelmann S, Otto S, Kuo CC,
Franzen J, Joussen S, Fernandez-Rebollo E, Rath B, Koch C, Hofmann
A, et al: The lncRNA HOTAIR impacts on mesenchymal stem cells via
triple helix formation. Nucleic Acids Res. 44:10631–10643. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Z, Chen Z, Fan R, Jiang B, Chen X,
Chen Q, Nie F, Lu K and Sun M: Over-expressed long noncoding RNA
HOXA11-AS promotes cell cycle progression and metastasis in gastric
cancer. Mol Cancer. 16:822017. View Article : Google Scholar : PubMed/NCBI
|
